Adagio Medical Holdings, Inc.
ADGM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | – | – | 100% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | 309.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | 39,353.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | 36,925.4% |
| EPS Diluted | -0.66 | -0.35 | -0.5 | -3.55 |
| % Growth | -88.6% | 30% | 85.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |